← Every applicant
Mylan Labs Ltd FDA Approvals
15 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| FERRIC CARBOXYMALTOSENew drugJun 25, 2026SOLUTION, INTRAVENOUS |
| LEVETIRACETAM IN SODIUM CHLORIDENew drugMay 8, 2026INJECTABLE, INTRAVENOUS |
| OCTREOTIDE ACETATENew drugDec 12, 2025INJECTABLE, INJECTION |
| IRON SUCROSENew drugAug 8, 2025INJECTABLE, INTRAVENOUS |
| AMPHOTERICIN BNew drugJun 30, 2025INJECTABLE, LIPOSOMAL, INJECTION |
| METHYLNALTREXONE BROMIDENew drugMay 28, 2025SOLUTION, SUBCUTANEOUS |
| DIFLUPREDNATENew drugMar 20, 2025EMULSION, OPHTHALMIC |
| GLUCAGONNew drugDec 12, 2024INJECTABLE, INJECTION |
| LOPINAVIR AND RITONAVIRNew drugFeb 7, 2024TABLET, ORAL |
| COBICISTATNew drugFeb 7, 2024TABLET, ORAL |
| POSACONAZOLENew drugDec 26, 2023SOLUTION, INTRAVENOUS |
| ROPIVACAINE HYDROCHLORIDENew drugOct 26, 2023SOLUTION, INJECTION |
| CABAZITAXELNew drugJul 5, 2023SOLUTION, INTRAVENOUS |
| TRIAMCINOLONE ACETONIDENew drugNov 2, 2022INJECTABLE, INJECTION |
| NALOXONE HYDROCHLORIDENew drugJun 9, 2022INJECTABLE, INJECTION |